Back to calendar
Larimar Therapeutics, Inc. (LRMR) Earnings
LRMR reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.35
Actual EPS: $-0.30
Company overview
Market Cap$394.5M
SectorHealth Technology
IndustryBiotechnology